Complete cure and adverse events for terbinafine vs griseofulvin: Proportion of participants with complete cure
Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Complete cure and adverse events for terbinafine vs griseofulvin Proportion of participants with complete cure · children with tinea capitis Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty). Systemic antifungal therapy for tinea capitis in children (2016) · Cochrane Headline outcomes only | RR 1.06 [0.98, 1.15] | 3 studies · 328 participants | Low |
Complete cure and adverse events for terbinafine vs griseofulvin Proportion of participants with complete cure · children with tinea capitis Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty). Systemic antifungal therapy for tinea capitis in children (2016) · Cochrane Headline outcomes only | RR 1.18 [0.74, 1.88] | 1 study · 1006 participants | Low |
Complete cure and adverse events for terbinafine vs griseofulvin Proportion of participants with complete cure · children with tinea capitis Complete cure and adverse events for terbinafine probably leads to lower proportion of participants with complete cure compared with griseofulvin (moderate certainty). Systemic antifungal therapy for tinea capitis in children (2016) · Cochrane Headline outcomes only | RR 0.68 [0.53, 0.86] | 2 studies · 334 participants | Moderate |
Complete cure and adverse events for terbinafine vs griseofulvin Proportion of participants with complete cure · children with tinea capitis Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty). Systemic antifungal therapy for tinea capitis in children (2016) · Cochrane Headline outcomes only | RR 0.45 [0.15, 1.35] | 1 study · 21 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.